StockTipsArenaBeta

BUY Granules India — Nilesh Jain, Centrum Broking

BUYGranules India
Granules India share price target & all analyst calls

byNilesh Jain, Centrum BrokingHorizon: NA (inferred Swing (≤2wk))29 Jun 2026via Business Today

Entry₹790Stated
Target₹830
Total upside +5.06% (call closed)
Stop loss₹770-2.53% risk
Exit—No position was opened
ExpiredNA
Follow Nilesh Jain for new calls(32% target hit, 138 closed calls)Get alertsWatch GRANULES for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 26 Oct, 12:03 am IST
2 supporting0 opposing
Supports the BUY call (2)

2 advisors have active short-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·7 Jul · 3d ago

Granules India Limited has secured sole first-to-file ANDA status for Sodium Oxybate Extended-Release for Oral Suspension.

NSE · Press Release·6 Jul · 4d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Granules India

All analyst calls on Granules India

More from Nilesh Jain, Centrum Broking

Every call and its outcome